Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement.
Jiyeon HyeonBoram LeeSo-Hyun ShinHae Yong YooSeok Jin KimWon Seog KimWoong-Yang ParkYoung-Hyeh KoPublished in: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (2018)
Gastric extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue is a distinct entity in that Helicobacter pylori infection plays the most important causative role in the development of the disease. To investigate the genomic alteration in gastric marginal zone lymphoma that was resistant to the H. pylori eradication therapy, we analyzed 19 cases of the gastric marginal zone lymphoma using fluorescence in situ hybridization for MALT1, BCL10 rearrangement, and targeted sequencing using an Illumina platform. Major genetic alterations affected genes involved in nuclear factor (NF)-κB pathway activation and included MALT1 rearrangement (39%), and somatic mutations of TRAF3 (21%), TNFAIP3 (16%), and NOTCH1 (16%). In the MALT1 rearrangement-negative group, disruptive somatic mutations of TRAF3 were the most common alterations (4/12, 33%), followed by somatic mutations of TNFAIP3 (3/12, 25%), and NOTCH1 (3/12, 25%). The present study confirms that genes involved in activation of NF-κB-signaling pathways are a major driver in oncogenesis of H. pylori eradication-resistant gastric marginal zone lymphoma and revealed that TRAF3 mutation is a major contributor in MALT1 rearrangement-negative gastric marginal zone lymphoma.
Keyphrases
- diffuse large b cell lymphoma
- helicobacter pylori infection
- nuclear factor
- signaling pathway
- copy number
- toll like receptor
- single cell
- helicobacter pylori
- pi k akt
- inflammatory response
- cancer therapy
- high throughput
- genome wide
- epithelial mesenchymal transition
- dna methylation
- mesenchymal stem cells
- induced apoptosis